The aim is to develop new PABA-based hybrids that act as dual inhibitors of DHPS and DHFR.
Synthesis of novel PABA-based compounds.
Evaluation of antimicrobial activity against resistant strains.
Computational studies using molecular dynamics and cytotoxicity assessments.
These PABA analogues displayed significant antimicrobial activity against resistant strains.
Computational studies supported their potential as DHPS/DHFR inhibitors.
Resumen
Novel PABA-based hybrids were developed as dual DHPS/DHFR inhibitors, showing promising antimicrobial activity against resistant strains supported by experimental and computational studies.